The Exonuclease Activity of Human Apurinic/Apyrimidinic Endonuclease (APE1)

BIOCHEMICAL PROPERTIES AND INHIBITION BY THE NATURAL DINUCLEOTIDE Gp4G*

Kai-ming Chou and Yung-chi ChengDagger

From the Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06520

Received for publication, December 1, 2002, and in revised form, January 10, 2003

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Human DNA apurinic/apyrimidinic endonuclease (APE1) plays a key role in the DNA base excision repair process. In this study, we further characterized the exonuclease activity of APE1. The magnesium requirement and pH dependence of the exonuclease and endonuclease activities of APE1 are significantly different. APE1 showed a similar Km value for matched, 3' mispaired, or nucleoside analog beta -L-dioxolane-cytidine terminated nicked DNA as well as for DNA containing a tetrahydrofuran, an abasic site analog. The kcat for exonuclease activity on matched, 3' mispaired, and beta -L-dioxolane-cytidine nicked DNA are 2.3, 61.2, and 98.8 min-1, respectively, and 787.5 min-1 for APE1 endonuclease. Site-directed APE1 mutant proteins (E96A, E96Q, D210E, D210N, and H309N), which target amino acid residues in the endonuclease active site, also showed significant decrease in exonuclease activity. Gp4G was the only potent inhibitor to compete against the substrates of endonuclease and exonuclease activities among all tested naturally occurring ribo-, deoxyribo-nucleoside/nucleotides, NAD+, NADP+, and Ap4A. The Ki values of Gp4G for the endonuclease and exonuclease activities of APE1 are 10 ± 0.6 and 1 ± 0.2 µM, respectively. Given the relative concentrations of Gp4G, 3' mispaired, and abasic DNA, Gp4G may play an important role in regulating APE1 activity in cells. The data presented here suggest that the APE1 exonuclease and AP endonuclease are two distinct activities. APE1 may exist in two different conformations, and each conformation has a preference for a substrate. The different conformations can be affected by MgCl2 or salt concentrations.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

DNA base excision repair is the main pathway to repair DNA base damages caused by oxidation, radiation, and the loss of bases (1, 2). There are several enzymes that participate in this pathway, including DNA polymerase beta , DNA ligase III-XRCC1 complex (1, 2), and apurinic/apyrimidinic endonuclease (APE1)1 to protect the genome integrity (1-3). The DNA repair activity of APE1 resides in the C-terminal region (4, 5). It endonucleolytically makes a nick immediately adjacent to 5' of an apurinic/apyrimidinic (AP) site and generates a hydroxyl group at the 3' terminus upstream of the nick and a 5'-deoxyribose phosphate moiety downstream (6). DNA polymerase beta  further processes the product of APE1 by inserting a nucleotide into the gap and releasing the 5'-deoxyribose phosphate by its intrinsic lyase activity (7). The repair process is then completed by either DNA ligase I or DNA ligase III/XRCC1 to seal the nicked DNA (1). During DNA base excision repair, DNA polymerase beta  is the major polymerase that incorporates a nucleotide into the gapped DNA (1). However, DNA polymerase beta  is a lower fidelity polymerase (8) in comparison to the replicating DNA polymerases delta  or epsilon  (9). The error rate of polymerase beta  is about 1 in 4000 incorporations (1).

APE1 is a versatile multifunctional protein (10). In addition to its endonuclease activity, it also possesses 3'-phosphatase, 3'-phosphodiesterase, RNase H, and 3'-5'-exonuclease activities (10). APE1 knockout mice die in the early embryonic stage (11), which indicates this protein is critical for development. Previously we reported (12) that the 3'-5'-exonuclease activity of APE1 is the major exonuclease activity in the human cell nucleus for the removal of the nucleoside analog beta -L-dioxolane-cytidine (L-OddC, BCH-4556, Troxacitabine, and Troxatyl) from the 3' termini of DNA. L-OddC is a novel nucleoside analog with L-configuration that is currently under phase III clinical trial and is showing promising activity for the treatment of leukemia (13, 14). The incorporation of L-OddC into DNA terminates DNA chain elongation because of the lack of the 3'-hydroxyl group on the sugar moiety of L-OddC. The cytotoxicity of L-OddC is proportional to the amount of L-OddC in DNA, suggesting that the mechanism of action of L-OddC is to stop DNA replication. Therefore, the exonuclease activity of APE1 may play a critical role in determining the cytotoxicity of L-OddC (15). We also discovered that APE1 has a significant preference for the removal of mispaired nucleotides from the 3' terminus of DNA when compared with matched pairs (16). Because physical interaction between polymerase beta  and APE1 had been established (17) and APE1 showed a significant preference for 3' mispaired nicked DNA (16), APE1 could be the proofreading enzyme correcting the misincorporations introduced by DNA polymerase beta  (16).

In addition to its DNA repair activities, APE1 was shown to possess redox activity, which regulates the DNA binding of a number of transcription factors, including Jun and Fos (18, 19). The redox activity of APE1 resides in the N-terminal region (5), and cysteine 65 is considered to be the active site (4, 20). Previous reports (4, 20) indicated that Cys-65 has no impact on the DNA endonuclease activity of APE1. The biological function of this redox activity of APE1 is, however, not well understood.

Several groups (21-23) have solved the crystal structure of APE1 in the presence or absence of abasic DNA. Mol et al. (22) reported the crystal structure of APE1-AP DNA complex and proposed a mechanism of action for the APE1 endonuclease activity in which amino acid Glu-96 binds to a metal ion, His-309/Asp-283 interacts with the phosphate backbone of DNA, and Asp-210 deprotonates a water molecule during nucleophilic attack on the AP site (22). Beernink et al. (23) subsequently proposed another mechanism of action based on the structure of APE1 crystallized under a neutral pH in the absence of AP DNA. According to the latter model, there are two metal-binding sites in the active center of APE1 endonuclease; Glu-96 is involved in coordinating one metal ion, which stabilizes the O-3' leaving group (23); and Asp-210 and His-309 coordinate the other metal ion to deprotonate a water molecule, which generates a nucleophile. In both models, Glu-96, Asp-210, and His-309 are involved in endonucleolytic activity of APE1. Mutations at these sites resulted in a significant decrease in endonuclease activity.

The monophosphate metabolites of ribonucleosides and several nucleoside analogs have been shown to have inhibitory effects on DNA exonucleases and DNA polymerase-associated exonucleases (24-27). In this study, we have characterized the biochemical properties of APE1 including optimal pH, Mg2+ requirements, and kinetic parameters of matched, 3' mispaired as well as L-OddC terminated DNA. The role of the specific amino acids Cys-65, Glu-96, Asp-210, and His-309 in the exonucleolytic action of APE1 was also examined. In addition, we have examined the potential inhibitory effects of naturally occurring ribonucleosides and deoxyribonucleosides and nucleotides on both exonuclease and endonuclease activities of APE1. Interestingly, among all the nucleosides and nucleotides, the dinucleotide compound Gp4G was the only potent inhibitor of both endonuclease and exonuclease activities of APE1. Gp4G is a product of GTP:GTP guanylyltransferase (28, 29) or originates from the low activity of mRNA capping enzymes (30). Although the detailed functions of Gp4G are not well understood in the cell, several Gp4G analogs were synthesized and shown to be substrates for human immunodeficiency virus-reverse transcriptase (30, 31). The inhibition of APE1 activities by Gp4G suggests a novel regulatory role of Gp4G for APE1 in cells.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials and Compounds-- [gamma -32P]ATP and terminal deoxynucleotidyltransferase were purchased from Amersham Biosciences. L-OddCTP was synthesized in our laboratory as described (31). T4 polynucleotide kinase was purchased from New England Biolabs (Beverly, MA). Gp4G was purchased from Sigma, and purity (>95%) was confirmed by high pressure liquid chromatography.

Oligonucleotide Substrates-- All oligonucleotides were synthesized by Integrated DNA Technology, Inc. (Coralville, IA), and further purified by electrophoresis on a 20% denaturing polyacrylamide gel. The 21-mer oligonucleotides were 5'-end-labeled with [gamma -32P]ATP using T4 polynucleotide kinase. The 32P-labeled 21-mer was then annealed to a 40-mer oligonucleotide to generate a recessed DNA with or without a mispair at the 3' terminus. To generate nicked mispaired and matched DNA, an additional 19-mer oligonucleotide was added for the annealing reaction. The sequences of the 3' mispaired recessed (Sequence 1) or nicked DNA (Sequence 2) are shown.



<UP><SC>Sequence</SC> 1</UP>


<UP><SC>Sequence</SC> 2</UP>
The sequence for the AP site analog (tetrahydrofuran, F) DNA (F-DNA) is shown in Sequence 3, 

<UP><SC>Sequence</SC> 3</UP>

Site-directed Mutagenesis-- The pET-28b expression plasmid containing wild type APE1 was a generous gift from Dr. Bruce Demple (Harvard University). Mutagenesis was performed by the PCR-based method using the QuickChange Site-directed Mutagenesis Kit (Stratagene). The primers used to create each mutant form are as follows: APE1-C65A primer, 5'-GCC ACA CTC AAG ATC GCC TCT TGG AAT GTG GAT GGG; APE 1-E96A primer, 5'-ATA CTG TGC CTT CAA GCG ACC AAA TGT TCA GAG AAC; APE 1-E96Q primer. 5'-ATA CTG TGC CTT CAA CAG ACC AAA TGT TCA GAG AAC; APE 1-D210E primer, 5'-CTT GTG CTG TGT GGA GAG CTC AAT GTG GCA CAT GAA; APE 1-D210N primer, 5'-CTT GTG CTG TGT GGA AAC CTC AAT GTG GCA CAT GAA; APE1-H309N primer, 5'-GCC CTC GGC AGT GAT AAC TGT CCT ATC ACC CTA TAC.

The DNA sequences of the expression plasmids containing the wild type or the site-directed mutant APE1 genes were confirmed by DNA sequencing at HHMI/Keck Facility, Yale University.

Purification of Recombinant APE1 and the Site-specific Mutant HAP1 Proteins-- The wild type and mutant pET-28b-APE1 constructs were expressed in Escherichia coli BL21(DE3) cells. The cells were grown at 37 °C in a shaking incubator until the culture reached an A600 of 0.6. Expression of APE1 from the T7 promoter was induced for 3 h by addition of 1 mM isopropyl-1-thio-beta -D-galactopyranoside (final concentration). The cells were then harvested and lysed by sonication, and the cell debris was pelleted by ultracentrifugation (27,500 rpm, 4 °C, 40 min in a Beckman 28 Ti rotor). The supernatant was dialyzed against nickel column binding buffer (Buffer A: 20 mM Tris-HCl, pH 7.4, 0.5 M NaCl, and 20 mM imidazole) before loading onto a Ni2+-charged His-trap fast protein liquid chromatography column (Amersham Biosciences), and the bound protein was eluted with a 20-300 mM imidazole gradient in binding buffer. The elution fractions that contained APE1 protein were pooled and dialyzed against Buffer A (20 mM Tris-HCl, pH 7.4, 10% glycerol, 1 mM dithiothreitol, 1 mM EDTA, and 20 mM NaCl). The dialyzed sample was then applied to a 1-ml fast protein liquid chromatography Hitrap SP XL column (Amersham Biosciences). The bound protein was eluted with a linear gradient of 100% Buffer A to 100% Buffer B (20 mM Tris-HCl, pH 7.4, 10% glycerol, 1 mM EDTA, and 1 mM dithiothreitol, 1 M NaCl).

The purified proteins were stored at -70 °C in storage buffer (20% glycerol, 20 mM NaCl, 20 mM Tris-HCl, pH 7.4, 1 mM EDTA). All proteins were >95% pure as judged by electrophoresis on 12% SDS-polyacrylamide gels stained with Coomassie Blue (data not shown).

Enzyme Assays-- Standard reaction (10 µl) mixtures contained 20 mM Tris-HCl, pH 7.5, 50 mM KCl, 0.1 mg/ml bovine serum albumin, optimal MgCl2, and various concentrations of DNA substrates and enzymes. The reaction mixtures were incubated at 37 °C for various times and then stopped by adding 4 µl of gel loading solution (90% formamide, 1 mM EDTA, 0.1% xylene cyanol, and 0.1% bromphenol blue) and heated at 80 °C for 3 min. Samples (4 µl) were loaded onto a 20% denaturing polyacrylamide gel for electrophoresis. The gel was then dried under vacuum and subjected to autoradiography and a PhosphorImaging screen (Bio-Rad). For kinetic analysis, the concentration of DNA substrates ranged from 1 to 500 nM at a fixed enzyme concentration. For each reaction, less than 25% of the substrates were converted to products by the enzyme, even at the lowest substrate concentration. All the kinetic data were determined based on the initial reaction rates.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The Optimal pH for the Exonuclease and Endonuclease Activities of APE1-- Two different crystal structures of APE1 were obtained under pH 6.2 and 7.5 (22, 23), which suggested that pH could cause conformational changes in APE1. We therefore determined the optimal pH for both the endo- and exonuclease activities of APE1 under otherwise identical reaction conditions. In addition, DNA substrates used shared the same length and sequence context to eliminate the potential influence of sequence context (see "Experimental Procedures"). As shown in Fig. 1a, optimal exonuclease activity was detected at pH 7.4 using a 3' mispaired nicked DNA as substrate, and the activity decreased dramatically as the pH increased. The optimal pH for endonuclease activity was observed between pH 7.7-7.9 using DNA containing an abasic site analog, tetrahydrofuran (F-DNA). Both activities decreased at pH 6.5 and lower.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 1.   The magnesium and salt requirements of APE1 endonuclease and exonuclease activities. a, the exonuclease and endonuclease activities at different pH values. Each reaction contains either 50 nM mispaired or F-DNA substrate and 48 pM APE1 under the standard assay conditions for 3 min at 37 °C under the pH value shown. The activities were normalized with the maximal activities (100%) at the tested pH. b, the profiles of APE endonuclease and exonuclease Mg2+ dependence. Each reaction contained 50 nM DNA substrate (3' mispaired recessed DNA, 3' mispaired nicked DNA, or F-DNA), 48 pM APE1, and different concentrations of MgCl2 at the standard reaction conditions for 5 min at 37 °C, pH 7.4. The activities were normalized with the maximal activities for each substrate at tested MgCl2 concentrations. c, the impact of NaCl on APE1 endonuclease and exonuclease activity. Each reaction contained 50 nM 3' mispaired nicked or F-DNA in the presence of 2 mM MgCl2, 20 mM Tris-HCl, pH 7.4, 48 pM APE1, and various concentrations of NaCl. The reaction mixtures were incubated at 37 °C for 5 min. This figure is representative of three independent experiments.

Magnesium Requirement for the Endonuclease and Exonuclease Activities of APE1-- Magnesium is required for the endonuclease activity of APE1, but high concentrations of magnesium inhibit this activity (32, 33). We have demonstrated previously (12) that magnesium is also required for the exonuclease activity of APE1. The recent crystal structure of APE1 revealed that there are two divalent metal ion-binding sites in the active center at neutral pH (7.5) (23), but only one divalent metal ion was observed in the crystal structure of the APE-DNA complex at pH 6.5 (22). This suggested that optimal Mg2+ concentrations for the endonuclease activity might vary under different assay conditions, e.g. pH. We therefore determined the optimal Mg2+ concentration required for the exo- and endonuclease activity at the same pH (7.4).

As shown in Fig. 1b, neither activity was observed in the absence of magnesium. The maximal exonuclease activity was observed between 0.1 and 1.0 mM MgCl2 on a 3' mispaired recessed DNA substrate. Interestingly, a higher concentration of MgCl2 was required to reach the maximal exonuclease activity for the removal of 3' mispair from a nicked DNA substrate. Similar Mg2+ dependence profiles were observed while using recessed or nicked DNA with L-OddC at the 3' terminus (data not shown). In contrast to the exonuclease activity, the endonuclease activity required a much higher magnesium concentration to reach its optimal activity (10-15 mM) under the same assay conditions.

The higher magnesium requirement for optimal endo- as compared with the exonuclease activity may be due to a need for higher ionic strength in the former reaction. In other words, both activities require a similarly low Mg2+ concentration (around 2 mM) for chemical catalysis, and the additional contribution of the metal (around 15 mM) to the endonuclease activity is to increase the ionic strength of the solution. To address this issue, both activities were monitored at 2 mM MgCl2 with increasing amounts of NaCl using either 3' mispaired nicked DNA or F-DNA as substrates. As shown in Fig. 1c, similar exonuclease activity was observed with 0-60 mM NaCl, but this activity decreased significantly above 100 mM. In contrast, the endonuclease activity increased in a salt-dependent manner. The maximal endonuclease activity was observed at 120 mM NaCl, the same activity as observed using 12.5 mM MgCl2 and 20 mM NaCl. The endonuclease activity decreased dramatically when the NaCl concentration exceeded 300 mM. Under a reaction mixture containing 12.5 mM MgCl2, only an inhibitory effect was observed with increasing concentrations of NaCl (data not shown). Thus, the higher MgCl2 concentration for optimal endonuclease activity did not appear to be a specific requirement during endonucleolytic catalysis.

The Steady-state Kinetic Studies of APE1 Exonuclease-- Because the magnesium and salt requirements for endonuclease and exonuclease activities are different, the kinetic parameters of both activities were studied under the optimal conditions for each activity of APE1. To determine the kcat and Km values, the exonuclease activity of APE1 was measured using varied concentrations (1-500 nM) of either a recessed or a nicked double-stranded DNA (see "Experimental Procedures"). Previous reports (34) showed discrepancies in the Km values of APE1 endonuclease; therefore, the kinetic properties of APE1 endonuclease activity on F-DNA were also examined for comparison. The Km and kcat values are summarized in Table I. The Km values of APE1 exonuclease for recessed 3' mispaired and L-OddC terminated DNA substrates were similar (37.8 ± 3.6 and 41.3 ± 6.2 nM, respectively) and 2-3-fold higher than those for nicked 3' matched, mispaired, L-OddC terminated DNA or F-DNA (16.2 ± 2.8, 12.6 ± 1.3, 19.8 ± 2.5, and 10.7 ± 1.5 nM, respectively). The AP endonuclease activity of APE1, which is considered to be the primary function of APE1 in cells, showed the highest kcat (787.5 min-1) using F-DNA as substrate. The APE1 exonuclease activity had a higher rate for the removal of L-OddC than the 3' mispaired nucleotides from the 3' terminus of either recessed or nicked DNA with kcat values for L-OddC terminated and 3' mispaired nicked DNA of 98.8 and 61.2 min-1, respectively. APE1 exonuclease showed the lowest activity on matched nicked DNA (kcat 2.3 min-1), which is about 35-fold less than that for the 3' mispaired DNA and 342-fold lower than the endonuclease activity on F-DNA under corresponding optimal reaction conditions.


                              
View this table:
[in this window]
[in a new window]
 
Table I
The kinetic parameter of APE1 DNA endonuclease and exonuclease
For endonuclease activity, the buffer contained 20 mM Tris-HCl, pH 7.4, 12.5 mM MgCl2, 20 mM NaCl, and 0.1 mg/ml bovine serum albumin. For the exonuclease activity on recessed DNA and nicked DNA, the same buffer was used but the MgCl2 concentrations were 0.1 and 2 mM, respectively. The enzyme concentration used for the exonuclease activity on 3' matched nicked DNA substrate was 100 pM. The enzyme concentration for 3' mispaired or L-OddC terminated recessed or nicked DNA was 11.1 pM. The enzyme concentration for the endonuclease activity on F-DNA was 1.2 pM.

The Roles of Specific Amino Acids Involved in the Exonuclease Activity-- The different magnesium requirements, salt dependence, and kinetic parameters for the endonuclease and exonuclease activities of APE1 suggested that amino acids involved in these two activities may play different roles during the reactions. To examine whether the exonuclease activity of APE1 shares the same amino acids in the active center with endonuclease activity, specific site-directed APE1 mutants of amino acids Glu-96, Asp-210, and His-309, which have been shown to be critical for the endonuclease activity (10, 33) were generated. The mutants were designed to probe the impact of both the electrostatic charge and spatial effects of these amino acid residues (see Table II). Cys-65, a key player in the redox activity of APE1 (4, 20) was also mutated to examine its potential involvement in the exonuclease activity of APE1. The specific activities were obtained from the initial reaction rate of the wild type, and mutant APE1 proteins on recessed and nicked DNA with a 3' mispair (sequences are shown under "Experimental Procedures") as well as F-DNA are presented in Table II. The endonuclease activity of wild type APE1 is about 30-fold higher than the exonuclease activity on 3' mispair from a nicked DNA and 80-fold higher than from the recessed DNA. Both endonuclease and exonuclease activities of Cys-65 mutant APE1 were similar to those of the wild type, which suggested that Cys-65 is not involved in either activity. Glu-96 was shown to be important for the magnesium coordination during APE1 endonuclease action (23). As shown in Table II, the endonuclease activity of E96A decreased 105-fold as compared with the wild type APE1. The exonuclease activity of E96A decreased about 104-fold on 3' mispaired recessed DNA and 6,100-fold on nicked DNA. E96Q showed better (~35-fold) exonuclease activity on both recessed and nicked 3' mispaired DNA than E96A. The Mg2+ dependence profiles of E96Q exonuclease activity were very similar to that of wild type, but the endonuclease activity of E96Q showed no significant change under different Mg2+ concentrations, although Mg2+ was required (Fig. 2a). Moreover, the product of E96Q endonuclease activity only increased slightly with time (Fig. 2b), which is not the pattern observed with wild type or other APE1 mutant proteins. To explore the interesting results of E96Q endonuclease activity, we performed a mobility retardation assay in the presence or absence of magnesium (Fig. 2c). The results showed that magnesium increased the formation of E96Q-F-DNA complex (Fig. 2c, lane 5). Under the same conditions, no complexes formed using wild type (Fig. 2c, lane 4) or other mutant APE1 proteins (data not shown), which suggested that dissociation of E96Q from its endonuclease product is very slow.


                              
View this table:
[in this window]
[in a new window]
 
Table II
The impact of amino acid mutations on the endonuclease and exonuclease activities of APE1
The specific enzyme activities of wild type or mutant APE1 proteins were determined by the initial reaction rates of their endonuclease and exonuclease activities in the presence of 50 nM F-DNA, mispaired recessed, or nicked DNA under their optimal reaction conditions (same as Table I). The concentrations of wild type and C65A mutant APE1 proteins used are the same as Table I. For E96A mutant APE1, 10 and 1.1 nM protein were used in the exonuclease and endonuclease assays, respectively. For E96Q mutant APE1, 10 nM enzyme was used for the endonuclease assay, and 3.3 and 1 nM protein were used for the 3' mispaired recessed and nicked DNA substrates, respectively. A final concentration of 10 nM enzyme was used for the endonuclease and exonuclease activity assays for D210E, D210N, and H309N mutant APE1.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 2.   The endonuclease activity of E96Q mutant APE1. a, the magnesium dependence of E96Q endonuclease. Each reaction contains 50 nM F-DNA and 5 nM E96Q mutant APE1 protein and increasing amounts of MgCl2, ranging from 0 to 30 mM (lanes 2-11). b, the time course study of E96Q endonuclease activity. Each reaction contains 50 nM F-DNA, 12.5 mM MgCl2, and 5 nM E96Q mutant APE1 protein for various times (lane 1, control DNA; lanes 2-6, 2, 4, 6, 8, 10 min, respectively). c, the mobility retardation study of E96Q mutant APE1 protein. Each reaction contains 10 nM F-DNA, wild type (10 nM), or E96Q (10 nM) mutant APE1 protein. The reaction mixtures were incubated at 37 °C for 5 min followed by addition of 20% glycerol before loading onto an 8% native PAGE gel for electrophoresis. The gel was exposed to a PhosphorImager screen. Lane 1, control DNA; lane 2, wild type APE with F-DNA in 5 mM EDTA; lane 3, E96Q with F-DNA in 5 mM EDTA; lane 4, wild type APE with F-DNA in 12.5 mM MgCl2; lane 5, E96Q with F-DNA in 12.5 mM MgCl2.

D210E mutant APE1 protein showed similar reduction in both endonuclease and exonuclease activities as the E96A mutant APE1 protein. D210N APE1 mutant protein also showed very low endonuclease and exonuclease activities. The H309N mutant APE1 showed no detectable exonuclease activity, and the endonuclease activity decreased more than 105-fold in comparison to the wild type. The double mutant E96A/D210A showed no endonuclease and exonuclease activities, which suggested that there is no compensatory effect between these two amino acids (data not shown).

With the exception of E96Q, the magnesium requirement profiles of C65A, E96A, and D210A were similar to those of the endonuclease or exonuclease activities of the wild type APE1 (data not shown).

Inhibition of Endonuclease and Exonuclease Activities of APE1 by Dinucleotide Gp4G-- The monophosphate metabolites of purine ribonucleosides and some nucleoside analogs were shown to inhibit DNA exonuclease activities (24-27). In this study, the naturally occurring ribo- and deoxyribonucleosides and their mono-, di-, and triphosphate metabolites, dinucleotide polyphosphate Ap4A and Gp4G, as well as the reduced and oxidized forms of NAD+ and NADP+ were examined for their potential inhibitory effect on APE1. Among all the tested compounds, only Gp4G showed significant inhibition of both endonuclease and exonuclease activities of APE1 (Table III and Fig. 3a). The IC50 values of Gp4G on the APE1 endonuclease activity on a F-DNA substrate and exonuclease activity on a 3' mispaired nicked DNA were 11 ± 1.1 and 1.2 ± 0.3 µM, respectively (Fig. 3b). To understand the nature of Gp4G inhibition on both APE1 activities, kinetic analysis was performed, and the results demonstrated that Gp4G was a competitive inhibitor with respect to the DNA substrates for both endonuclease and exonuclease activities of APE1. The Ki values were 1 ± 0.2 µM for the exonuclease and 10 ± 0.6 µM for endonuclease activity (Fig. 3, c and d).


                              
View this table:
[in this window]
[in a new window]
 
Table III
The inhibitory effects of nucleoside and nucleotides on the endonuclease and exonuclease activity of APE1
To monitor exonuclease activity, each reaction contains 20 nM 3' mispaired nicked DNA, 2 mM MgCl2, 20 mM Tris-HCl, pH 7.4, 11.1 pM APE1, and tested nucleosides/nucleotides (5mM) for 5 min at 37 °C, and the final concentrations of reduced/oxidized forms of NAD and NADP, Ap4A, and Gp4G in the reaction were 0.5 mM. For endonuclease activity, each reaction contains 20 nM F-DNA, 12.5 mM MgCl2, 20 mM Tris-HCl, pH 7.4, 1.2 pM APE1, for 3 min at 37 °C. The concentrations of compounds tested were the same as used in the exonuclease assay.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   The inhibition of exonuclease and endonuclease activities of APE1 by Gp4G. a, the inhibitory effects of dinucleotides Ap4A and Gp4G. For exonuclease activity (lanes 1-4), each reaction contains 20 nM 3' mispaired nicked DNA, 2 mM MgCl2, 20 mM Tris-HCl, pH 7.4, 11.1 pM APE1, and 0.5 mM Ap4A or Gp4G (lane 1, control DNA; lane 2, APE1 only; lane 3, APE1 and Ap4A; lane 4, APE1 and Gp4G). The reaction mixtures were incubated at 37 °C for 5 min. For endonuclease activity (lanes 5-8), each reaction contains 20 nM F-DNA, 12.5 mM MgCl2, 20 mM Tris-HCl, pH 7.4, 1.2 pM APE1, and 0.5 mM Ap4A or Gp4G. Lane 5, control DNA; lane 6, APE1 only; lane 7, APE1 and Ap4A; lane 8, APE1 and Gp4G. b, the inhibition of exonuclease activity (lanes 1-8) and endonuclease activity (lanes 9-16). For exonuclease activity, the reaction conditions are the same as described in a in the presence of various concentrations of Gp4G (lane 1, control DNA; lanes 2-8, 0, 0.01, 0.03, 1, 2, 3, and 10 µM, respectively). The reaction mixtures were incubated at 37 °C for 5 min. For endonuclease activity, reaction conditions are the same as a in the presence of various concentrations of Gp4G (lane 9, control DNA; lanes 10-16, 0, 1, 3, 10, 20, 30, and 100 µM, respectively). The results were analyzed by denaturing gel and exposed to a PhosphorImager screen for quantitation. The IC50 represented is the concentration of Gp4G required to inhibit 50% of the reaction. c, Gp4G competitively inhibits exonuclease activity of APE1. The reaction condition is the same as described in Table I in addition to various concentrations of Gp4G (0-2 µM). The Ki value (1 ± 0.2 µM) was determined by the K<UP><SUB><IT>m</IT></SUB><SUP>app</SUP></UP> under different concentrations of Gp4G. d, Gp4G competitively inhibits APE1 endonuclease activity. The reaction conditions are the same as described in Table I in addition to various concentrations of Gp4G (0-30 µM). The Ki value (10 ± 0.6 µM) was determined by the K<UP><SUB><IT>m</IT></SUB><SUP>app</SUP></UP> under different concentrations of Gp4G. This figure is representative of three independent experiments.

APE1 exists as a monomer in the cell (10), and there is only one active site found within in this enzyme (22, 23). Therefore, the Ki values of a competitive inhibitor on both endonuclease and exonuclease should theoretically be the same. Because the optimal concentrations of MgCl2 for endonuclease and exonuclease activities are different, it is possible that MgCl2 may affect the Km and Ki values. To address this issue, the Km and Ki values of APE1 endonuclease activity were determined under the optimal MgCl2 concentration for APE1 exonuclease activity (2 mM). The results indicated that both the Km and Ki values of endonuclease activity under this condition were similar to those under higher MgCl2 concentration (12.5 mM) (data not shown) but kcat decreased, suggesting that the MgCl2 has no significant impact on Km and Ki values. In addition, the Km value of APE1 exonuclease at 12.5 mM MgCl2 did not show a significant change (<2-fold). The Ki value of Gp4G on exonuclease, under 12.5 mM MgCl2, could not be obtained as the long incubation time caused non-enzymatic breakdown of Gp4G.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We demonstrated previously (12) that APE1 is the major exonuclease that removes the unnatural L-configuration nucleoside analog, L-OddC, as well as other L-nucleoside analogs from DNA. We subsequently discovered that the exonuclease activity of APE1 has a significant preference for the removal of 3' mispaired nucleotides from DNA over the matched ones (16). Because physical interaction between APE1 and DNA polymerase beta  has been established, this novel 3' mispair removal function of APE1 could explain why the mutation rate is lower than expected, given that the error rate of DNA polymerase beta  is 1 per 4000, and at least 104 abasic sites are generated per cell per day (1).

In this report, we have further characterized the biochemical properties of the exonuclease activity of APE1. Several crystal structures of APE1 have been solved in the presence or absence of abasic DNA under different crystallization conditions (21-23). Based on the structures, different mechanisms of action were proposed for the endonuclease activity of APE1. The latest crystal structure solved by Beernink et al. (23) indicated that there are two divalent ion binding sites in the APE1 active center under neutral pH. Given the fact that the optimal pH for APE1 endonuclease activity is between 6.6 and 8.6 (23), the crystal structure solved under neutral pH could be a more favorable conformation during the endonuclease action of the enzymes. However, because the structure was crystallized in the absence of DNA, the structure of APE1 bound to abasic DNA at neutral pH is still not clear. As different structures of APE1 were obtained under different pH, the optimal pH for the exonuclease activity of APE1 was examined and compared with that of the endonuclease activity. The results indicated that pH 7.4 is optimal for the exonuclease activity as well as for the endonuclease activity, and this observation agrees with a previous report (23).

Both endonuclease and exonuclease activities require magnesium for the catalytic reactions (12, 33). At pH 7.5, the optimal magnesium requirement for exonuclease activity (0.1-2 mM) is substantially lower than that of endonuclease (10-15 mM). Interestingly, as shown in Fig. 1c, at a low MgCl2 concentration (2 mM) NaCl could achieve the same endonuclease activity as the higher concentration of MgCl2 (12.5 mM). This suggests that both endonuclease and exonuclease activities of APE1 may have the same MgCl2 requirement; however, the higher MgCl2 concentration requirement for the optimal endonuclease activity may not be specific because NaCl can achieve the same activity. The crystal structure showed that the abasic DNA was severely distorted from B-form DNA during the endonuclease action (22). Although the Km values of APE1 exonuclease on 3' mispaired nicked DNA and endonuclease on F-DNA are very similar, despite different MgCl2 concentrations (2 and 12.5 mM, respectively), the structure of nicked DNA is very different from AP-DNA (no strand breakage). Therefore, the higher concentrations of MgCl2 or NaCl may facilitate the enzyme conformation changes to favor its action on F-DNA.

The Km of APE1 exonuclease on recessed DNA is about 3-fold higher than on the nicked or F-DNA, which suggested that APE1 could have higher affinity for nicked or F-DNA than the recessed DNA. It also explains the higher efficiency of APE1 in the removal of 3' mispaired nucleotide from nicked than the recessed DNA (16), although the kcat values are similar for both substrates. In contrast, the kcat value of exonuclease on the matched DNA is significantly lower than for either 3' mispaired or L-OddC DNA. These data further support our previous results (16) that APE1 has a higher efficiency for the removal of 3' mispaired nucleotides than matched nucleotides from DNA. DNAs with L-OddC at the 3' terminus were better substrates for the APE1 exonuclease activity as compared with the 3' mispaired DNAs, because the kcat values are higher than those for the 3' mispaired DNA on both recessed and nicked DNA. The unnatural L-configuration of L-OddC may cause a distortion in DNA rendering it a more favorable substrate. Under the optimal reaction conditions, F-DNA is the most favorable substrate for APE1, and the kcat value of endonuclease activity was 9- and 6-fold higher than the exonuclease activity on the 3' mispaired or L-OddC terminated nicked DNA, respectively. More detailed pre-steady-state kinetic parameters are being explored to further the understanding of the interactions between APE1 and various DNA substrates as well as the catalysis of endonuclease and exonuclease cleavage.

The crystal structure of APE1 revealed that there is only one active center in APE1 (21-23), although different mechanisms of action for the endonuclease have been proposed. The redox activity of APE1 resides within the N-terminal region, and Cys-65 has been implicated to be the active center (4, 5, 19). The site-directed Cys-65 mutant APE1 protein was shown to possess similar endonuclease activity as wild type (4, 20). In this report, we further showed that C65A mutant APE1 has similar exonuclease activity as the wild type APE1 on both recessed and nicked 3' mispaired DNA. These data further support that Cys-65 is not involved in the DNA repair activity of APE1.

All the crystal structures of APE1, obtained under various crystallization conditions, indicated that amino acids Glu-96, Asp-210, and His-309 were critical for the endonuclease activity (21-23). The site-directed mutagenesis results shown in Table II indicated that mutation of Glu-96 to alanine reduced both exonuclease and endonuclease activities of APE1 significantly (104 and 105, respectively), which suggested that Glu-96 was critical but might have a different impact on the two enzyme activities. The exonuclease activity of E96Q decreased about 230-fold as compared with that of the wild type APE1 (but was ~35-fold higher than that of E96A), which indicated that the carboxyl group of Glu-96 might be critical for both enzyme activities. Moreover, E96Q endonuclease activity did not require higher MgCl2 concentration. Mobility shift studies using native gel electrophoresis showed the E96Q mutant but not the wild type or other mutant APE1 proteins bound to F-DNA in the presence of magnesium (12.5 mM). To explore whether E96Q APE1 and F-DNA formed covalent bonds, the complexes were boiled in the presence of SDS and electrophoresed on an SDS-PAGE gel. No complexes were observed after electrophoresis (data not shown), which indicated that no covalent bonds formed in the complex. These results suggested that the dissociation of E96Q mutant from its AP endonuclease product is very slow, and Glu-96 is critical in determining the kcat value for APE1 endonuclease activity. Glu-96 was proposed to play important roles in magnesium placement, and the lack of dose dependence for magnesium and the slow dissociation of E96Q from its DNA product suggested that the higher ionic strength requirement for the optimal APE1 endonuclease activity is needed for the enzyme to disassociate from its product.

The APE1 D210E mutant protein also showed a significant decrease in both endonuclease and exonuclease activities, although the substituted glutamic acid can provide the same carboxyl group as the aspartic acid. This indicated that steric hindrance has a profound effect on the enzyme reaction. The D210N mutant APE1 showed extremely low exonuclease and endonuclease activities, which supported the critical role of carboxyl group of glutamic acid (35). The H309N mutant showed very low exonuclease and endonuclease activities. Interestingly, the Glu-96 and Asp-210 APE1 mutant proteins, with the exception of E96Q, showed similar magnesium requirement profiles for endonuclease and exonuclease activities as the wild type APE1 on 3' mispaired recessed DNA, nicked DNA, and F-DNA. We conclude that all the amino acids studied in this report are important for both endonuclease and exonuclease activities of APE1, but their roles in the two reactions may not be identical.

AMP and GMP were shown to be inhibitors for a number of DNA polymerase-associated exonuclease activities (24-27, 36). Here we report that the APE1 endonuclease and exonuclease activities cannot be inhibited by AMP, GMP, and other natural nucleoside or their mono-, di-, and triphosphate metabolites. Interestingly, Gp4G but not Ap4A competitively inhibited both activities of APE1. The intracellular concentration of Gp4G in mammalian cells is not clear yet; however, the physiological concentrations of Gp4G was shown to be in the nanomolar to micromolar range in rat tissues and human blood platelets (40, 41). In addition, the concentrations of Gp4G were in the nanomolar to micromolar ranges in Saccharomyces cerevisiae and E. coli cells, depending on the growth condition (37). In exponentially growing S. cerevisiae cells, the Gp4G concentration was determined to be 60 nM, whereas after the temperature shift to a non-growing condition, the concentration of Gp4G increased to 1.15 µM (37). This implies that the concentration of Gp4G may be higher in nonproliferating tissues in mammals. In Artemia salina, Gp4G comprises as high as 50% of the total nucleotide pool (10 mM) in dormant cysts, which was suggested to serve as a source of purine for DNA synthesis (38). It was also proposed that Gp4G regulates the activity of endoribonuclease VI in Artemia, by alternating its concentration under different developmental stages (39). An in vitro experiment has shown that Gp4G activates GMP reductase activity in both Artemia and human erythrocytes at nanomolar concentrations (41, 42). Grau et al. (43) proposed a relationship between Gp4G binding capacity and the time of development of rat embryos. It was also suggested that Gp4G might play a role in the regulation of organ perfusion and vascular growth (40).

Interestingly, Gp4G can also be used as a primer for template-directed synthesis of virus-specific oligonucleotides and RNA (30, 44). Furthermore, Gp4G can be synthesized by some viral mRNA guanylyltransferases when RNA capping is uncoupled from methylation and elongation (30). Several carbocyclic and 2'-deoxy analogs of Gp4G were shown to be substrates for human immunodeficiency virus-reverse transcriptase (30, 31), which suggested that Gp4G may also affect viral replication. Given the specificity and potency reported in this study and potential different concentrations of Gp4G in different intracellular compartments as suggested by others (38, 39), it is conceivable that Gp4G may play important roles in regulating the enzyme activities of APE1 in the cell nucleus.

In summary, this report reveals that APE1, in addition to its most preferable endonuclease activity on abasic sites, also has very good activity on 3' mispaired DNA and DNA terminated with the unnatural L-configuration nucleoside analogs. Both endonuclease and exonuclease activities of APE1 may have similar active centers, but the amino acids involved may play different roles during each reaction. MgCl2 is required for both activities, but higher ionic strength is required for endonuclease activity. It is possible that higher ionic strength induces a change to a endonuclease-favored conformation. The different Ki values of Gp4G on the two activities further supported the hypothesis that APE1 may have two different conformations in equilibrium, and the conformations can be affected by higher concentrations of MgCl2 or NaCl. Gp4G may have different affinity to these two forms; one form has a preference for the exonuclease activity (lower ionic strength), and the other form favors endonuclease activity (higher salt and magnesium requirement). We are currently solving the co-crystal structures of APE1 with 3' mispaired nicked DNA under different conditions to address this question.

    ACKNOWLEDGEMENTS

We thank Drs. Wing Lam, Zafer Hatahet, and Adrian S. Ray for valuable discussions.

    FOOTNOTES

* This work was supported by National Institutes of Health Grants CA 73477 and AI 38204.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Pharmacology, Yale University School of Medicine, 333 Cedar St., SHM B315, New Haven, CT 06520. Tel.: 203-785-7119; Fax: 203-785-7129; E-mail: cheng.lab@yale.edu.

Published, JBC Papers in Press, March 6, 2003, DOI 10.1074/jbc.M212143200

    ABBREVIATIONS

The abbreviations used are: APE1, human apurinic/apyrimidinic endonuclease; L-OddC, beta -L-dioxolane cytidine; Gp4G, P1,P4-di(guanosine-5') tetraphosphate; Ap4A, P1,P4-di(adenosine-5') tetraphosphate; F-DNA, DNA containing a tetrahydrofuran; AP, apurinic/apyrimidinic..

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Lindahl, T. (2000) Mutat. Res. 462, 129-135[CrossRef][Medline] [Order article via Infotrieve]
2. Lindahl, T., and Wood, R. D. (1999) Science 286, 1897-1905[Abstract/Free Full Text]
3. Wilson, D. M., III, and Barsky, D. (2001) Mutat. Res. 485, 283-307[Medline] [Order article via Infotrieve]
4. Walker, L. J., Robson, C. N., Black, E., Gillespie, D., and Hickson, I. D. (1993) Mol. Cell. Biol. 13, 5370-5376[Abstract]
5. Xanthoudakis, S., Miao, G. G., and Curran, T. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 23-27[Abstract]
6. Wilson, D. M., III, Takeshita, M., Grollman, A. P., and Demple, B. (1995) J. Biol. Chem. 270, 16002-16007[Abstract/Free Full Text]
7. Matsumoto, Y., and Kim, K. (1995) Science 269, 699-702[Medline] [Order article via Infotrieve]
8. Kunkel, T. A. (1985) J. Biol. Chem. 260, 5787-5796[Abstract]
9. Bambara, R. A., and Jessee, C. B. (1991) Biochim. Biophys. Acta 1088, 11-24[Medline] [Order article via Infotrieve]
10. Evans, A. R., Limp-Foster, M., and Kelley, M. R. (2000) Mutat. Res. 461, 83-108[Medline] [Order article via Infotrieve]
11. Xanthoudakis, S., Smeyne, R. J., Wallace, J. D., and Curran, T. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 8919-8923[Abstract/Free Full Text]
12. Chou, K. M., Kukhanova, M., and Cheng, Y. C. (2000) J. Biol. Chem. 275, 31009-31015[Abstract/Free Full Text]
13. Grove, K. L., Guo, X., Liu, S. H., Gao, Z., Chu, C. K., and Cheng, Y. C. (1995) Cancer Res. 55, 3008-3011[Abstract]
14. Giles, F. J., Garcia-Manero, G., Cortes, J. E., Baker, S. D., Miller, C. B., O'Brien, S. M., Thomas, D. A., Andreeff, M., Bivins, C., Jolivet, J., and Kantarjian, H. M. (2002) J. Clin. Oncol. 20, 656-664[Abstract/Free Full Text]
15. Grove, K. L., and Cheng, Y. C. (1996) Cancer Res. 56, 4187-4191[Abstract]
16. Chou, K. M., and Cheng, Y. C. (2002) Nature 415, 655-659[CrossRef][Medline] [Order article via Infotrieve]
17. Bennett, R. A., Wilson, D. M., III, Wong, D., and Demple, B. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 7166-7169[Abstract/Free Full Text]
18. Xanthoudakis, S., Miao, G., Wang, F., Pan, Y. C., and Curran, T. (1992) EMBO J. 11, 3323-3335[Abstract]
19. Xanthoudakis, S., and Curran, T. (1992) EMBO J. 11, 653-665[Abstract]
20. Walker, L. J., Craig, R. B., Harris, A. L., and Hickson, I. D. (1994) Nucleic Acids Res. 22, 4884-4889[Abstract]
21. Gorman, M. A., Morera, S., Rothwell, D. G., de La Fortelle, E., Mol, C. D., Tainer, J. A., Hickson, I. D., and Freemont, P. S. (1997) EMBO J. 16, 6548-6558[Abstract/Free Full Text]
22. Mol, C. D., Izumi, T., Mitra, S., and Tainer, J. A. (2000) Nature 403, 451-456[CrossRef][Medline] [Order article via Infotrieve]
23. Beernink, P. T., Segelke, B. W., Hadi, M. Z., Erzberger, J. P., Wilson, D. M., III, and Rupp, B. (2001) J. Mol. Biol. 307, 1023-1034[CrossRef][Medline] [Order article via Infotrieve]
24. Huang, P. (1998) Oncogene 17, 261-270[CrossRef][Medline] [Order article via Infotrieve]
25. Tsurumi, T. (1992) Virology 189, 803-807[Medline] [Order article via Infotrieve]
26. Pelicano, H., Kukhanova, M., and Cheng, Y. C. (2000) Mol. Pharmacol. 57, 1051-1055[Abstract/Free Full Text]
27. Skalski, V., Liu, S. H., and Cheng, Y. C. (1995) Biochem. Pharmacol. 50, 815-821[CrossRef][Medline] [Order article via Infotrieve]
28. McLennan, A. G. (2000) Pharmacol. Ther. 87, 73-89[CrossRef][Medline] [Order article via Infotrieve]
29. Liu, J. J., and McLennan, A. G. (1994) J. Biol. Chem. 269, 11787-11794[Abstract/Free Full Text]
30. Smith, R. E., and Furuichi, Y. (1982) J. Biol. Chem. 257, 485-494[Abstract/Free Full Text]
31. Ruth, J. L., and Cheng, Y. C. (1981) Mol. Pharmacol. 20, 415-422[Abstract]
32. Barzilay, G., Mol, C. D., Robson, C. N., Walker, L. J., Cunningham, R. P., Tainer, J. A., and Hickson, I. D. (1995) Nat. Struct. Biol. 2, 561-568[Medline] [Order article via Infotrieve]
33. Barzilay, G., Walker, L. J., Robson, C. N., and Hickson, I. D. (1995) Nucleic Acids Res. 23, 1544-1550[Abstract]
34. Sokhansanj, B. A., Rodrigue, G. R., Fitch, J. P., and Wilson, D. M., III (2002) Nucleic Acids Res. 30, 1817-1825[Abstract/Free Full Text]
35. Rothwell, D. G., Hang, B., Gorman, M. A., Freemont, P. S., Singer, B., and Hickson, I. D. (2000) Nucleic Acids Res. 28, 2207-2213[Abstract/Free Full Text]
36. Derse, D., and Cheng, Y. C. (1981) J. Biol. Chem. 256, 8525-8530[Abstract/Free Full Text]
37. Coste, H., Brevet, A., Plateau, P., and Blanquet, S. (1987) J. Biol. Chem. 262, 12096-12103[Abstract/Free Full Text]
38. Warner, A. H., and McClean, D. K. (1968) Dev. Biol. 18, 278-293[Medline] [Order article via Infotrieve]
39. Grau, P. P., and Heredia, C. F. (1988) FEBS Lett. 236, 291-294[CrossRef][Medline] [Order article via Infotrieve]
40. Schluter, H., Grobeta, I., Bachmann, J., Kaufmann, R., van der Giet, M., Tepel, M., Nofer, J. R., Assmann, G., Karas, M., Jankowski, J., and Zidek, W. (1998) J. Clin. Invest. 101, 682-688[Abstract/Free Full Text]
41. Renart, M. F., Renart, J., Sillero, M. A., and Sillero, A. (1976) Biochemistry 15, 4962-4966[Medline] [Order article via Infotrieve]
42. Spector, T., Jones, T. E., and Miller, R. L. (1979) J. Biol. Chem. 254, 2308-2315[Medline] [Order article via Infotrieve]
43. Grau, V. P., Sillero, M. A., and Sillero, A. (1982) J. Biol. Chem. 257, 11848-11851[Abstract/Free Full Text]
44. Yamakawa, M., Furuichi, Y., and Shatkin, A. J. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 6142-6146[Abstract]


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.